skip to Main Content

基于区块链的早期乳腺癌检测

1 代币 = 0,00026 ETH
10 代币 = 1 乳腺癌测试
1 乳腺癌测试 = 100 – 500$ (取决于国家)

预售成功完成
代币总数已发布: $883.323

ARNA代币销售已经开始

如果您愿意以10个以上eth来支持我们并获取特别奖励,或者以50个以上eth来支持我们并参与贵宾俱乐部,请注册

匿名购买代币,请把eth发至
chart
1 (1)
ARNA Panacea ICO rating
награда

ARNA代币的实用功能现已可用

您可以将10个ARNA代币换为1ARNA BC测试。
ARNA BC候补名单已于2017年12月21日开放申请。
现在就报名吧,以确保您在数百万人前面。

您有机会进入生物技术市场

ARNA Genomics是一家创新的生物技术公司,从事研究和开发基于区块链生态系统ARNA Panacea的肿瘤疾病早期检测方法及其市场推广。

overview

ARNA BC 是首个高精度乳腺癌早期检测的产品。

什么是 ARNA

ARNA顾问 Dmitry Kulish 讲述了有关ARNA项目和区块链技术。 采访全文

ARNA Genomics 简介

ARNA Panacea 介绍

ARNA Panacea是一种生物技术分散式解决方案,
由区块链和ARNA 代币提供支持

ARNA Panacea的设计是一个平台,不仅可以处理临床试验数据,还可以支持研发阶段和在研究阶段市场所有类型的市场参与者参与临床试验,以及将最终生物技术产品直接销售给客户(患者)。

准确性
2018年5月
96.04%
准确: 97 错误: 4
laptop

ARNA Panacea使用案例

研究证明

研究证明

存储在公共区块链ARNA Panacea中的数据将成为临床证据库的基础。

受保护的研究

受保护的研究

在区块链生态系统中使用加密密钥以安全格式进行“科学研究”的能力

大数据

大数据

通过开放的API接口全面访问累积的信息,并具有分析可用数据所需的功能。

生态系统

生态系统

一个用于收集、储存和分析癌症诊断和治疗信息的区块链平台

智能区块链

智能区块链

连接人工智能以寻找开发新的癌症治疗方法的“模式”的可能性

ARNA代币

ARNA代币

通过在患者、研究人员、监管机构、CRO、制药公司、诊所的生态系统中的互动

我们的市场是巨大的

0B
每年全球妇女
0
数千名生物技术研究人员
0M
ARNA BC仅在美国和俄罗斯进行测试
$0M
过去3年每个医疗市场的并购交易

ARNA Panacea 区块链生态系统

社区角色

  • 01 保险公司
  • 02 诊所
  • 03 医生
  • 04 大数据
  • 05 患者
  • 06 专家
  • 07 合同研究机构 (CRO)
  • 08 全国伦理委员会
  • 09 注册
  • 10 监管机构
  • 11 统计
  • 12 制药公司
  • 13 赞助商/投资者
  • 14 研究人员

我们的愿景

革命性地将颠覆性的对抗癌症的生物技术通过使用区块链 技术推向大众市场

团队

Egor Melnikov

Egor Melnikov

Founder, CEO

More than 10 years ago started the project with mission to save lives from cancer. Economist and manager by education, entrepreneur by experience and spirit. Made several successful startups as founder and co-founder in advertising and production business, international logistics, IT solutions for large-scale projects, was CEO of international telecom operator. ARNA – is the meaning of Egor’s life.

George Nikitin

George Nikitin

Co-founder and COO, blockchain platform ideologist

Master of physics (diploma with honors), have 14 articles and inventions. Successfully worked in large international companies (Delloite, etc.), as well as in private equity companies. He has extensive experience as executive manager in various major private and public companies in IT, telecom, oil&gas.

Anatoliy Melnikov

Anatoliy Melnikov

Co-founder and HEAD of R&D, creator of ARNA tests

Having more than 40 years of experience in molecular biology and genetics, he is the author and co-author of more than 50 scientific articles and number of patents. For 15 years he worked in the USA in oncological centers, before that – in Canada, Hungary in various scientific companies, and Russia – a branch of the Institute of Bioorganic Chemistry of the Russian Academy of Sciences and the Institute of Biochemistry and Physiology of Microorganisms of the Russian Academy of Sciences. He graduated from the biological faculty of the Lomonosov Moscow State University.

Ilya Senechkin

Ilya Senechkin

PhD in Life Sciences, Embryology Director ("Center IVF" network of clinics, Russia)

Development Manager for Scientific and Educational Programs (F. Paulsen Assisted Reproductive Technologies Center, Russian Ministry of Health). Former: medical advisor (MC Femina, Vitrolife), clinical embryologist (MD Medical Group), Jr. scientist (Wageningen University, The Netherlands)

Magomed Chatuev

Magomed Chatuev

Software architect and developer

CTO. Has a big experience working with start-ups in the areas of e-commerce, PR & Marketing, finance, transportation, ERP development. Mainly focused on building SaaS, APIs & complex business processes automation. Had been working in international companies in Russia, Ireland, and Germany.

Alexander Mazaletskiy

Alexander Mazaletskiy

Software Architect

Founder, CEO and Principal engineer in blockchain integrator Dicoiner (www.dicoiner.com) Founder and CEO in mobile development studio Zero Cool Team. 10 years experience in enterprise fintech software design and development. Last two yeast making research and implementation of blockchain systems. Graduate of IIDF-2015(Internet Initiatives Development Fund) in the team of Teslawatch startup.
15 scientific publications in the field of natural language processing

Sergey Dolgachev

Sergey Dolgachev

Co-founder, head of finance and risks management

Entrepreneur and co-owner of several companies in the oilfield service, medicine and biotech. He graduated from the Faculty of Computational Mathematics and Cybernetics of the Moscow State University Lomonosov, EMBA Higher School of Economics, studied at the Skolkovo Management School, INSEAD and graduate school of MGIMO. He has extensive executive experience in oil&gas public and private companies.

Vladimir Savanovich

Vladimir Savanovich

Co-founder, Head of Investor Relations

has a master’s degree in physics. During his professional experience, he worked in various business areas, mainly focusing on the active development of the contractual base of enterprises. He has experience in working in a Western consulting company, a resort development company, a Swiss investment fund and a Russian exploration company.

顾问

Linda S. Pellicore

Linda S. Pellicore

Linda S. Pellicore graduated from Thomas Jefferson Medical College of Graduate Studies, Philadelphia, PA, with Ph.D.s in both Pharmacology and Toxicology, in 1987. She has 28 years expertise in New Drug Applications, Biologics, 510Ks, Food Additives and Dietary Supplements with the U.S. Food and Drug Administration, serving as the agency’s Senior Pharmacologist. She is a National Research Council Fellow, and is a member of numerous professional scientific societies.

Wesley Hymer, Ph.D

Wesley Hymer, Ph.D

Dr. Hymer is an Emeritus Professor of Biochemistry at Penn State and winner of Penn State’s Faculty Scholar Medal for Life and Medical Sciences. He has countless academic papers, grants and including several patents that were developed when he was Director of Penn State’s Center for Cell Research, and one patent related to medical devices enabling targeted chemotherapy for cancers treatments. He collaborated with NASA on biotechnology and biomedical experiments in microgravity and developed unique electrophoresis experiments executed on board the U.S. Space Shuttle and microsatellites.

Dmitry Kulish

Dmitry Kulish

Dmitry Kulish is an independent expert in the fields of strategic, organizational and technological development of pharmaceutical products. Dmitry holds a PhD in Biology, has been a postdoc at Harvard Medical School, earned MBA from the Wharton Business School, the Institute of Molecular Genetics of the Russian Academy of Sciences, and the Moscow State Institute of Molecular Biology Lomonosov Moscow State University.

Dmitry Grigoriev

Dmitry Grigoriev

Over 20 years of successful general management experience with a particular focus on business development and operational excellence. Сonstant over 5 years trend in business development and financial results improvement for large European integrated company with over 8 bln. USD in turnover and presence in over 15 countries. Has implemented several very successful business alliances strategies where the managed companies/clients have benefited from new distribution channels/partners reach.

Ph.D DR. Soenke Bartling

Ph.D DR. Soenke Bartling

Ph.D DR. MED, Board certified Radiologist, blockchain for research & healthcare / Open Science. Sönke has a tremendous background in neuroradiology at Hannover Medical School, Institute for Radiology and Interventional Therapy and other sound scientific organizations. Apart from that Sönke is well-known due to his activity in Web 2.0 for science in 00x, following by working on Blockchain for Science and Open Science (awarded in 2015, Germany land of ideas) concepts. He is author of more than 20 scientific publications, number of reviews, books and 6 patents. Holds various awards and is a member of governmental groups on radiology and tomography.
Mikhail Groubman

Mikhail Groubman

Mikhail joined Atlant Clinical in 2012 as Chief Executive Officer and as a member of the Board of Directors. Prior to Atlant Clinical he worked at GlaxoSmithKline where he started as a clinical research assistant, later becoming a local study manager in the oncology group. He subsequently joined the Moscow Sales Department, where he rose to become Regional Market Access Director. Mikhail graduated from Lomonosov Moscow State University with Master degrees in biochemistry and management.

Marina Sekacheva

Marina Sekacheva

is a Doctor of Medical Sciences, a laureate of the Russian Government Prize in Science, a holder of post-doctoral degree in medicine of the Technical University of Munich, the Director of the Center for Personalized Oncology Sechenov OncoTarget, established as part of the Institute of Personalized Medicine in 2017

Ilya N. Chistyakov

Ilya N. Chistyakov

MD., PhD, founder and CEO of the Preclinical Study Centre LLC, managing company of “Pharma Valley” biotechnological cluster – the only GLP OECD in Russia, an independent hybrid CRO specialized on conducting a full cycle of pharmacological development, manufacturing, preclinical and clinical studies of biotechnological, biosimilar and generic medicines.

Ed Kanalosh

Ed Kanalosh

has more than 20 years of experience in biotech investments and strategic consulting. Partner of venture fund “Maxwell Biotech” (Moscow), director of consulting company Candesic (London). Edward is an acting head of Investment Service of Skolkovo fund, vice-president of Investment Bank “Trust” and consultant of New Jersey office of McKinsey company. His career has started in Bill and Melinda Gates Foundation Fund. MBA from Harvard Business School, MD with PhD.

Alex Kosik

Alex Kosik

Dr. Alex Kоsik is a successful serial technology entrepreneur. His focus is in Life Sciences, Medical Devices, FDA Compliance, Evidence-Based Medicine, Venture Capital and M&A. Alex is a recognized technology due diligence expert and senior analyst to several VC’s, angels, Gerson Lehrman Group and institutional investors. He co-founded multiple businesses himself, met Bill Gates, sold his “G1 Gravitonus workstations” to Forbes-100, and ranked 3rd by Becker’s Spine Review of “10 spine orthopedic surgeon tech entrepreneurs to know”

Sergey Borovskiy

Sergey Borovskiy

worked and lived in China since 1991. He has more than 20 years of experience in international management in China and Hong Kong. He held the positions of Chairman of the Board of Directors in various companies in China involved in international trade, investment and production. Since 2017, he was the General Manager of Sanju Environmental Protection (Hong Kong) Limited, coordinating the international projects of the controlling shareholder.

代币有什么功能

B2 Dir

JANET WOODCOCK – (美国食品和药物管理局药物评估和研究中心主任)

“就像其他许多人一样,我个人认为,我们现在所拥有的临床试验系统已经被打破了。它没有达到我们所需要的目标”

  • 来自主销售事件的10个代币(0.000266 ETH)可购买1次ARNA BC测试。 一次ARNA BC测试的预期平均市场价格为0.33333ETH。
  • 持有大量代币的人将有资格参加ARNA VIP奖励计划 ARNA VIP Reward Program,提供前所未
  • ARNA代币将用于ARNA Panacea平台,作为平台参与者之间的支付的加密货币。
  • 研究人员将能够在生物科技领域突破性发明方面进行“众筹”活动。
  • 还有其他用途 请阅读我们的白皮书。

代币和基金

ARNA论坛

[big-v2]conference2

莫斯科

International blockchain forum

[big-v2]conference3

摩纳哥 

MGF Holiday Blockchain Edition CryptoBazar Exclusive

[big-v2]conference1

纽约

Blockchain economic forum 2017

[big-v2]conference5

香港

The 30th Annual AVCJ Private Equity & Venture Forum

[big-v2]conference6

洛杉矶

World funding summit & capital expo

[big-v2]conference4

圣克拉拉

Blockchain in the healthcare system

文件

文件

chwp

单页

ARNA market overview

市场概况

Market-Overview

发展历程

2013 2019
[carousel_anything]

2013

建立了ARNA Genomics
获得了Skolkovo生物医学集群成员的地位

2014

种子基金; 开发ARNA-Thermometr,
对肿瘤疾病的测试;
“专有技术”对象规范化

2015

开发ARNA Breast Cancer ——乳腺癌早期高精度检测检测

2016

发展ARNA Colon Cancer;
ARNA BC开发完成;
ARNA BC实验室测试开始;
提交1号专利申请

2017

ARNA BC实验室测试结束;
与安捷诺夫大学联合开始ARNA BC临床研究;
提交专利合作条约第1号申请;
代币分发事件

2018

在美国开设办公室和第一个实验室; 提交专利合作条约第2号和第3号申请; 对ARNA BC的监管策略协议。 美国FDA推出临床研究第1号; ARNA CC开发完成,开始实验室研究; ARNA Panacea – 推出区块链生态系统的beta版本,为开发者提供基本文档。

2019

感兴趣的市场参与者(监管者、投资者、用户等)使用ARNA Panacea区块链生态系统; 开始开发:ARNA Lung, ARNA Liver, ARNA Pancreas; BCNA进入美国市场; 中国临床试验; 国家阶段:美国、中国、印度、欧盟、英国、以色列、巴西; 种子基金B; 获得第一笔收入。

[/carousel_anything]

伙伴

媒体

logo-300×77
steemit
NewsBTC-Logo
logo-home-new
forclog
coin-min
logo
Безымянный
tokenmarket
coingecko-logo
cryptocoinsnews-vector-kopi-1-1
smith+crown
3423420
1.Bitcoininsider
2.Themerkle
3. THE COINTELEGRAPH 11
4.Huffpost
5.NEWS